Prioritization of adverse events related to integrase inhibitors and NNRTIs: a disproportionality analysis using data from the FAERS database

Key Points

• The aim is to evaluate the post-marketing adverse events associated with integrase inhibitors and NNRTIs.
• Utilized a semi-quantitative scoring system for adverse events.
• Conducted a disproportionality analysis using the FAERS database.
• Identified and ranked adverse events based on priority.
• Five high-priority adverse events were identified.
• These events require clinical validation and further investigation.